Innovative Eyewear, Inc. last reported quarterly results on Oct 8, 2026, for Q1 FY2026 (the quarter ended Sep 30, 2026). It usually reports 7–8 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 6, 2027.
Results for Q2 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Jan 7, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 7–8 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 8, 2026
8 days after quarter end
|
Q1 FY2026
ended Sep 30, 2026
|
—
|
—
|
—
|
|
Jan 7, 2026
7 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
1
+39.0%
|
-2
+12.0%
|
-0.35
+60.1%
|
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- LUCY (Nasdaq), LUCYW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1808377
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Cooper Companies, Inc. COO
- Bausch & Lomb Corp BLCO
- Warby Parker Inc. WRBY
- National Vision Holdings, Inc. EYE
- Staar Surgical Co STAA
- RxSight, Inc. RXST
Source: SEC EDGAR filings. This is company-reported data, not investment advice.